Skip to main content
Log in

Epidermal growth factor receptor content in rat prostatic adenocarcinoma: effects of endocrine treatment

  • Original Paper
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

Epidermal growth factor receptor (EGF-R) was studied in Dunning prostatic cancer models using competitive bindings assays and solution hybridization assay. EGF-R-binding capacity and mRNA were demonstrated in a hormone-sensitive R3327 prostatic tumor from both control and castrated animals while no such activity was found in the hormone-independent AT-1 tumors. Castration induced no quantitative changes in the EGF-R. Estrogen treatment induced a significant reduction of the binding capacity of EGF-R and its mRNA. It was concluded that EGF-R is present in the androgen-sensitive Dunning prostatic tumor models (R3327), but that the androgen-insensitive, undifferentiated AT-1 tumor lacks EGF-R expression. Endocrine treatment has no significant effect on the EGF-R in these tumor models.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Benraad TJ, Foekens JA (1990) Hydroxyapatite assay to measure epidermal growth factor receptor in human primary breast tumors. Ann Clin Biochem 27:272

    Google Scholar 

  2. Chabot J-G, St-Arnaud R, Walker P, Pelletier G (1986) Distribution of epidermal growth factor receptors in the ovary. Mol Cell Endocrinol 44:99

    Google Scholar 

  3. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294

    Google Scholar 

  4. Davies P, Eaton CL (1989) Binding of epidermal growth factor by human normal, hypertrophic and carcinomatous prostate. Prostate 14:123

    Google Scholar 

  5. Davies P, Eaton CL (1991) Regulation of prostate growth J Endocrinol 131:5

    Google Scholar 

  6. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH (1987) Synthesis of mRNA's for transforming growth factors and the epidermal growth factor receptor for human tumors. Cancer Res 47:707

    Google Scholar 

  7. Downward J, Parker P, Waterfield RA (1984) Autophosphorylation sites on the epidermal growth factor receptor. Nature 311:483

    Google Scholar 

  8. Durnam DM, Palmiter RD (1983) A practical approach for quantitating specific mRNAs by solution hybridization. Anal Biochem 131:385

    Google Scholar 

  9. Eaton CL, Davies P, Phillips MEA (1988) Growth factor involvement and oncogene expression in prostatic tumours. J Steroid Biochem 30:341

    Google Scholar 

  10. Eaton CL, Davies P, Harper M, France T, Rushmere N, Griffiths K (1991) Steroids and the prostate. J Steroid Biochem Mol Biol 40:175

    Google Scholar 

  11. Ekberg S, Carlsson L, Carlsson B, Billig H, Jansson J-O (1989) Plasma growth hormone pattern regulates epidermal growth factor (EGF) receptor messenger ribonucleic acid levels and EGF binding in the rat liver. Endocrinology 125:2158

    Google Scholar 

  12. Fiorelli G, DeBellis A, Longo A, Pioli P, Costantini A, Giannini S, Forti G, Serio M (1991) Growth factors in the human prostate. J Steroid Biochem Mol Biol 40:199

    Google Scholar 

  13. Habib FK, Maddy SQ (1987) Are epidermal growth factor receptors present in the human prostate. In: Peeters H (ed) Protides of the biological fluids. Pergamon Press, p 315

  14. Habib FK, Chisholm GD (1991) The role of growth factors in the human prostate. Scand J Urol Nephrol 138 [Suppl]:53

    Google Scholar 

  15. Huggins C, Stevens RE Jr, Hodges CV (1941) Studies on prostatic cancer II. The effects of castration on advanced carcinoma of the prostate. Arch Surg 43:209

    Google Scholar 

  16. Isaacs JT (1987) Development and characterization of the available model systems for the study of the prostatic cancer. In: Coffey DS, Bruchovsky N, Gardner WH, Resnik MJ, Kerr JP (eds) Current concepts and approaches to the study of prostate cancer. Liss, New York, p 513

    Google Scholar 

  17. Klijn JGM, Berns PMJJ, Schmitz PIM, Foekens JA (1992) The clinical significance of epidermal growth factor receptor (EGFR) in human breast cancer: a review on 5232 patients. Endocr Rev 13:3

    Google Scholar 

  18. Landström M (1992) Endocrine treatment of prostatic adenocarcinoma. An experimental study in the rat. Umeå University Medical Dissertations, New Series No 346, Umeå, Sweden

  19. Landström M, Bergh A, Tomic R, Damber J-E (1990) Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the dunning R 3327 rat prostatic adenocarcinoma. Prostate 17:57

    Google Scholar 

  20. Landström M, Damber J-E, Bergh A, Tomic R (1992) Doseresponse study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma. J Cancer Res Clin Oncol 118:30

    Google Scholar 

  21. Liang S-G, Taketani Y, Mizuno M (1990) Estradiol stimulates the binding of epidermal growth factor in cultured rat granulosa cells. Endocrinol Jpn 37:893

    Google Scholar 

  22. Liu A, Davis RJ, Flores C, Menon M, Seethalakshmi L (1992) Epidermal growth factor: receptor binding and effects on the sex accessory organs of sexually mature male mice. J Urol 148:427

    Google Scholar 

  23. Lubrano C, Petrangeli E, Catizone A, Santonati A, Concolino G, Rombola N, Frati L, DiSilverio F, Sciarra F (1989) Epidermal growth factor binding and steroid receptor content in human benign prostatic hyperplasia. J Steroid Biochem 34:499

    Google Scholar 

  24. MacDonald A, Chisholm GD, Habib FK (1990) Production and response of a human prostatic cancer line to transforming growth factor-like molecules. Br J Cancer 62:579

    Google Scholar 

  25. MacDonald A, Habib FK (1992) Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Br J Cancer 65:177

    Google Scholar 

  26. Maddy SQ, Chisholm GD, Busuttil A, Habib FK (1989) Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumor. Br J Cancer 60:41

    Google Scholar 

  27. Matuo Y, McKeehan WL, Yan GC, Nikolaropoulos S, Adams PS, Fukabori Y, Yamanaka H, Gaudreau J (1992) Potential role of HBGF (FGF) and TFG-α on prostate growth. Adv Exp Med Biol 324:107

    Google Scholar 

  28. Maygarden SJ, Strom S, Ware JL (1992) Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Arch Pathol Lab Med 116:269

    Google Scholar 

  29. Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MR (1984) Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res 12:7035

    Google Scholar 

  30. Morris GL, Dodd JG (1990) Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol 143:1272

    Google Scholar 

  31. Neal DE, Bennett MK, Hall RR, Marsh C, Abel PD, Sainsbury JRC, Harris AL (1985) Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet I:366

    Google Scholar 

  32. Peeling WB, Griffiths K (1986) Endocrine treatment of prostatic cancers. In: Blandy JP, Lytton B (eds) The prostate. Butterworths, London, p 188

    Google Scholar 

  33. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular cloning, a laboratory manual. Cold Spring Harbor Press, New York

    Google Scholar 

  34. Schuurmans ALG, Bolt J, Mulder E (1988) Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumour cell line LNCaP. Prostate 12:55

    Google Scholar 

  35. St-Arnaud R, Poyet P, Walker P, Labrie F (1989) Androgens modulate epidermal growth factor receptor levels in the rat ventral prostate. Mol Cell Endocr 56:21

    Google Scholar 

  36. Thompson TC (1990) Growth factors and oncogenes in prostate cancer. Cancer Cells 2:345

    Google Scholar 

  37. Tillotson JK, Rose DP (1991) Endogenous secretion of epidermal growth factor peptides stimulates growth of DU145 prostate cancer cells. Cancer Lett 60:109

    Google Scholar 

  38. Traish AM, Wotiz HH (1987) Prostatic epidermal growth factor receptors and their regulation by androgens. Endocrinology 121:1461

    Google Scholar 

  39. Turkes AO, Peeling WB, Griffiths K (1987) Treatment of patients with advanced cancer of the prostate: phase III trial, Zoladex against castration. A study by the British Prostate Group. J Steroid Biochem 27:543

    Google Scholar 

  40. Ullrich A, coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH (1984) Human epidermal growth factor receptor cDNA sequence and abberant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309: 418

    Google Scholar 

  41. Ware JL (1993) Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev 12:287

    Google Scholar 

  42. Waterfield MD, Mayers ELV, Stroobant P, Bennett PLP, Young S, Goodfellow PN, Banting GS, Ozanne B (1982) An antibody to the human epidermal growth factor receptor. J Cell Biochem 20:149

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Damber, J.E., Bergh, A., Assarsson, B. et al. Epidermal growth factor receptor content in rat prostatic adenocarcinoma: effects of endocrine treatment. Urol Res 23, 119–125 (1995). https://doi.org/10.1007/BF00307942

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00307942

Key words

Navigation